Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 3Gastrointestinal 3Breast 3Dermatologic 2Other hematologic neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Kidney Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Paclitaxel 37Bevacizumab 34Carboplatin 30pembrolizumab 25Specimen Handling 21Magnetic Resonance Spectroscopy 19olaparib 18Cisplatin 15liposomal doxorubicin 13Taxes 13Immunoglobulin G 12Gemcitabine 12Disulfides 12Topotecan 9Nivolumab 9Cyclophosphamide 9Biopsy 9mirvetuximab soravtansine 7Doxorubicin 7fludarabine 6Radiation 6Fulvestrant 6niraparib 5durvalumab 5cediranib 5atezolizumab 5Platinum 5Oxaliplatin 5Fluorouracil 51,2-diaminocyclohexaneplatinum II citrate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Early Intervention, Educational × Gynecologic × 30 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡